Clinical Trial Update: CAR-T Combined With ASCT in the Treatment of Relapsed/Refractory Large B-cell Lymphoma With High-risk Factors. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating CAR-T cell therapy combined with autologous stem cell transplantation for high-risk relapsed/refractory diffuse large B-c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CAR-T cell therapy

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: High-risk R/R LBCL | Phase 2 | Status: NOT_YET_RECRUITING